Cargando…
Arctigenin suppresses fibroblast activity and extracellular matrix deposition in hypertrophic scarring by reducing inflammation and oxidative stress
Hypertrophic scars (HSs) are a progressive fibroproliferation disorder caused by abnormal tissue repair after deep skin injury, and are characterized by continuous activation of fibroblasts and excessive deposition of extracellular matrix. Arctigenin (ATG), a phytomedicine derived from certain plant...
Autores principales: | Jiang, Ling, Deng, Ying, Li, Wei, Lu, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7646887/ https://www.ncbi.nlm.nih.gov/pubmed/33174021 http://dx.doi.org/10.3892/mmr.2020.11539 |
Ejemplares similares
-
Smad-binding decoy reduces extracellular matrix expression in human hypertrophic scar fibroblasts
por: Fan, Chen, et al.
Publicado: (2020) -
The interplay of fibroblasts, the extracellular matrix, and inflammation in scar formation
por: Moretti, Leandro, et al.
Publicado: (2021) -
Suppressive effects of human fetal keratinocytes on the proliferation, differentiation and extracellular matrix synthesis of human hypertrophic scar fibroblasts in vitro
por: Wang, Zhe, et al.
Publicado: (2017) -
Cuprous oxide nanoparticles reduces hypertrophic scarring by inducing fibroblast apoptosis
por: Xiao, Yongqiang, et al.
Publicado: (2019) -
Comparative proteomic analysis of extracellular matrix proteins secreted by hypertrophic scar with normal skin fibroblasts
por: Ma, Li, et al.
Publicado: (2014)